Bioequivalence and Bioavailability Forum 02:18 CET

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

MaggieSantos
Junior

Portugal,
2018-07-03 18:41

Posting: # 19015
Views: 439
 

 Topical Drugs- IVRT [Regulatives / Guidelines]

Hello,

Regarding the new draft guidance on acyclovir ointment I have performed an IVRT test to compare the test and reference formulations. I used a Hanson system similar to the ones used for acyclovir creams.

During the validation of the test system, I applied the described parameters on draft guidance for acyclovir cream, namely, IVRT Discrimination Sensitivity, Specificity and Selectivity.

When comparing the lower (2.5%) and upper (7.5%) release rates to the 5% acyclovir ointment (PEG basis), the release rates were nor discriminatory.

As anyone performed this test, what results were obtained and what is the suggested reason for no discriminatory results. What is the impact?:confused:

Kind Regards

MeggieSantos
Activity
 Thread view
Bioequivalence and Bioavailability Forum |  Admin contact
19,037 posts in 4,061 threads, 1,300 registered users;
online 16 (0 registered, 16 guests [including 13 identified bots]).

An expert is a man who has made all the mistakes,
which can be made, in a very narrow field.    Niels Bohr

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed